01-01-1970 12:00 AM | Source: ICICI Direct
Buy Cyient Ltd For Target Rs. 1,200 - ICICI Direct
News By Tags | #872 #3048 #3961 #409 #1302

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

DLM impacted, services to drive growth…

About the stock: Cyient Ltd (Cyient) offers engineering & development services to aerospace & defence, transportation, E&U, communication and others.

* Cyient has 300 customers across 14 countries

* Net debt free and healthy cash flow with OCF/EBITDA ~80%

 

Q3FY22 Results: Cyient reported strong Q3FY22 results.

* Services revenue grew 3.6% QoQ (4.4% in CC) while DLM revenues grew 12.8% QoQ. This resulted into overall revenue growth of 5.2% QoQ

* Group EBIT margins came in at 13.9%. Services margins were up 14 bps QoQ while that of DLM came in at 6%

* DLM growth guidance revised downward from 15-20% in FY22 to low single digit growth

 

What should investors do? Cyient’s share price has grown by ~2.3x over the past five years (from ~| 408 in January 2017 to ~| 963 levels in January 2022).

* We continue to remain positive and retain our BUY rating on the stock

Target Price and Valuation: We value Cyient at | 1,200 i.e. 18x P/E on FY24E EPS

 

Key triggers for future price performance:

* Improving outlook on aerospace vertical

* Improved demand from large deals, healthy order book, rebound in DLM business and organisation restructuring to accelerate growth

* Margins to improve led by improved revenue growth and SG&A rationalisation

 

Alternate Stock Idea: Apart from Cyient, in our IT coverage we also like Infosys.

* Strong revenue guidance prompts us to be positive

* BUY with a target price of | 2,300

 

To Read Complete Report & Disclaimer Click Here

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer